Detalhe da pesquisa
1.
First-line therapy for adults with advanced renal cell carcinoma: a systematic review and network meta-analysis.
Cochrane Database Syst Rev
; 5: CD013798, 2023 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37146227
2.
Chimeric antigen receptor (CAR) T-cell therapy for people with relapsed or refractory diffuse large B-cell lymphoma.
Cochrane Database Syst Rev
; 9: CD013365, 2021 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34515338
3.
Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer).
Cochrane Database Syst Rev
; 7: CD012556, 2018 07 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30001476
4.
Meta-epidemiological review identified variable reporting and handling of time-to-event analyses in publications of trials included in meta-analyses of systematic reviews.
J Clin Epidemiol
; 159: 174-189, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37263516
5.
GRADE concept 4: rating the certainty of evidence when study interventions or comparators differ from PICO targets.
J Clin Epidemiol
; 159: 40-48, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37146659
6.
Association of Supporting Trial Evidence and Reimbursement for Off-Label Use of Cancer Drugs.
JAMA Netw Open
; 4(3): e210380, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33651108
7.
GRADE Guidelines: 29. Rating the certainty in time-to-event outcomes-Study limitations due to censoring of participants with missing data in intervention studies.
J Clin Epidemiol
; 129: 126-137, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33007458
8.
GRADE guidelines 27: how to calculate absolute effects for time-to-event outcomes in summary of findings tables and Evidence Profiles.
J Clin Epidemiol
; 118: 124-131, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31711910
9.
["Transferability": Is GRADE the solution?] / "Übertragbarkeit? Ist GRADE die Lösung?
Z Evid Fortbild Qual Gesundhwes
; 140: 52-57, 2019 Mar.
Artigo
em Alemão
| MEDLINE | ID: mdl-30824313
10.
Methodological review showed correct absolute effect size estimates for time-to-event outcomes in less than one-third of cancer-related systematic reviews.
J Clin Epidemiol
; 108: 1-9, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30543910
11.
A systematic assessment of Cochrane reviews and systematic reviews published in high-impact medical journals related to cancer.
BMJ Open
; 8(3): e020869, 2018 03 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29581210